Works matching IS 03407004 AND DT 2003 AND VI 52 AND IP 9


Results: 7
    1
    2
    3
    4
    5
    6

    Safety, biodistribution, pharmacokinetics, and immunogenicity of <sup>99m</sup>Tc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck.

    Published in:
    Cancer Immunology, Immunotherapy, 2003, v. 52, n. 9, p. 576, doi. 10.1007/s00262-003-0396-5
    By:
    • Colnot, David R.;
    • Roos, Jan C.;
    • de Bree, Remco;
    • Wilhelm, Abraham J.;
    • Kummer, J. Alain;
    • Hanft, Gertraud;
    • Heider, Karl-Heinz;
    • Stehle, Gerd;
    • Snow, Gordon B.;
    • van Dongen, Guus A. M. S.
    Publication type:
    Article
    7